China Resources Sanjiu completes restricted share repurchase, reducing capital

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. announced the completion of its restricted share repurchase and cancellation, effective September 9, 2025. A total of 5,333,927 restricted shares were cancelled, representing 0.319% of the company's total share capital before the repurchase. The total funds used for the repurchase amounted to CNY 34,551,411.32.

This action reduced the company's total share capital from 1,669,588,290 shares to 1,664,254,363 shares. The repurchase primarily involved shares from employees who terminated employment, retired, or whose performance targets for the third unlocking period of the 2021 restricted stock incentive plan were not met.

The repurchase price was set at CNY 5.7817625 per share for most of the cancelled restricted shares, with an additional bank deposit interest for some. The company confirmed that the cancellation complied with all relevant laws and regulations, using its own funds. It does not significantly impact its financial status or ongoing incentive plan implementation.